Lakefront Biotherapeutics (LKFT) EBT Margin Growth (3y) (2017 - 2026)
Lakefront Biotherapeutics (LKFT) EBT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 49,756.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 441.00 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | 23,477.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,477.00 |
| Dec 31, 2025 | 4,947.00 |
| Sep 30, 2025 | -65,069.00 |
| Mar 31, 2025 | -20,006.00 |
| Dec 31, 2024 | 5,570.00 |
| Jun 30, 2024 | -21,678.00 |
| Mar 31, 2024 | 4,786.00 |
| Dec 31, 2023 | 2,582.00 |
| Sep 30, 2023 | 2,886.00 |
| Jun 30, 2023 | 9,265.00 |
| Mar 31, 2023 | 2,909.00 |
| Dec 31, 2022 | 4,877.00 |
| Sep 30, 2022 | -7,335.00 |
| Mar 31, 2022 | 13,853.00 |
| Dec 31, 2021 | -1,544.00 |
| Jun 30, 2021 | 6,862.00 |
| Mar 31, 2021 | 8,706.00 |
| Dec 31, 2020 | 1,013.00 |
| Sep 30, 2020 | 8,350.00 |
| Jun 30, 2020 | 1,685.00 |